iZO Promo Review
Fictional brands · Sample data as of 12 Oct 2026
Claims by status
1Approved

Claim C-001

One governed record per claim. Approved once with its risk information, then reused in every piece.

Claim record · Brand X (illustrative)

Claim text
[Outcome A] reached by Week 12 in [Study 1]
Reference
[Study 1] primary analysis, Table [x]; PI Section 14.1
Risk information
ISI-01 · Brand X Important Safety Information (ISI) v3
Status
Approved
Expiry date
15 Mar 2027154 days from 12 Oct 2026
Message strength
82Score from message testing (placeholder)
Audience and channelProposed field
HCP specialist · Email, Sales aid, Leave-behind
Treatment stageProposed field
First-line initiation

Fair balanced claim — reviewed and approved as a pair

Claim C-001

[Outcome A] reached by Week 12 in [Study 1]

ISI-01

Approved

Brand X Important Safety Information (ISI) v3

[Boxed warning, contraindications, warnings and precautions, most common adverse reactions — approved ISI text placeholder]

Shown with the claim in every pieceStored once, linked to 10 claims. Terms vary by company: ISI, IRI or fair balance language.

Status

New
Review
● Approved
Modified
Expiring <60 days
Prior approval expired
FDA removed
Sign-off:

Status history

  1. 15 Mar 2026 — Approved — expiry date setMarketing ops coordinator
  2. 20 Feb 2026 — Sent to review (Medical, Regulatory, Legal)Marketing ops coordinator
  3. 2 Feb 2026 — Created as New, reference attachedMarketing ops coordinator

Used in pieces (4)

Design rules

  • Smallest approvable unit — if two claims must always appear together, they become one claim.
  • Risk information stored once — fair balance and safety language is linked to claims, not copied.
  • One record, many pieces.

What moves a status

  • • Expiry date approaching or passed
  • • Label updates: new data, indications, boxed warnings, monitoring
  • • FDA actions
  • • Removal letters

Every return to Approved passes through Medical, Regulatory and Legal.